LRRK2 and Parkinson disease: Current studies indicate that LRRK2 rodents partly replicate the spectrum of changes reported in prodromal PD patients although whether these changes really represent early events in a slow process leading to neuronal loss and synuclein pathology or just the impact of the LRRK2 mutations on rodent brain remains a matter for speculation.